Remifentanil vs. alfentanil infusion in non-paralysed patients: a randomized, double-blind study

Autor: Mortensen, C R, Larsen, B, Petersen, J A K, Rotbøll, P, Riist, J, Thorshauget, H, Engbaek, J, Troelsen, S, Viby-Mogensen, J

Publikováno v: Mortensen, C R, Larsen, B, Petersen, J A K, Rotbøll, P, Riist, J, Thorshauget, H, Engbaek, J, Troelsen, S & Viby-Mogensen, J 2004, ' Remifentanil vs. alfentanil infusion in non-paralysed patients : a randomized, double-blind study ', European Journal of Anaesthesiology, vol. 21, no. 10, pp. 787-92 . https://doi.org/10.1017/s0265021504000067

BACKGROUND AND OBJECTIVE: Remifentanil has a short duration of action and constant elimination, which allow administration of high doses, without prolonging recovery. Remifentanil has been compared to alfentanil, as part of a total intravenous anaest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22804d3a93f20c0967aa6b89c4882dd5
https://doi.org/10.1097/00003643-200410000-00006

Systemic treatment with epidermal growth factor in the rat. Biomechanical properties of the growing small intestine

Autor: Vinter-Jensen, L., Duch, B. U., Petersen, J. A. K., Ryslev, A., Gregersen, H.

Publikováno v: Regulatory Peptides; 1996, Vol. 61 Issue: 2 p135-142, 8p